SCNXScienture Holdings, Inc.

Is Scienture Holdings struggling financially?

Yes, by its own account. Scienture Holdings told the SEC on 15 May 2026, in Form 10-Q, that there is substantial doubt about its ability to continue as a going concern.

Going concern disclosed May 2026

15/100

Critical

Sector
Biotech/Pharma
Market cap
$18.5M
Source filing
10-Q 15 May 2026
Balance sheet
30 Jun 2026

Cash runway

  • 3months

    If the burn speeds up

    Empty by Sep 2026

  • 6months

    If it eases off

    Empty by Dec 2026

Both rows are the same reported burn flexed 15% either way, and neither assumes the company raises a cent.

Out of cashTwo years or more

The runway math

Cash and short-term investments

$8.2M

÷

Cash burned over the last 12 months

$22.4M

What Scienture Holdings told the SEC

…limited to: Our limited amount of cash; The negative effect on our business and our ability to raise capital that is created by the fact that there is a substantial doubt about our ability to continue as a going concern; Our limited revenue generating operations, and risks of our operations not being profitable; Claims relating to alleged violations of intellectual property rights of others;…

Scienture Holdings, Inc., Form 10-Q, filed 15 May 2026.

Read the filing on SEC.gov

What this means

  • Not a bankruptcy filing, and not a prediction.
  • It is the company’s own statement, agreed with its auditor, that the doubt is material enough to disclose.
  • The runway is arithmetic on two reported numbers, not a forecast. Companies carry this language for years, raise money and keep going.

What else the numbers show

  • 234.5% share-count increase The company issued stock. Each share now owns 70.1% less of the business than a year ago, before any change in the price.

Other Biotech/Pharma companies that filed the doubt